Abstract
Background Descriptions of the COVID-19 pandemic’s indirect consequences on children are emerging. We aimed to describe the impacts of the pandemic on children with medical complexity (CMC) and their families.
Methods A one-time survey of Canadian paediatricians using the Canadian Paediatric Surveillance Program (CPSP) was conducted in Spring 2021.
Results A total of 784 paediatricians responded to the survey, with 70% (n=540) providing care to CMC. Sixty-seven (12.4%) reported an adverse health outcome due to a COVID-19 pandemic-related disruption in healthcare delivery. Disruption of the supply of medication and equipment was reported by 11.9% of respondents (n=64). Respondents reported an interruption in family caregiving (47.5%, n=252) and homecare delivery (40.8%, n=218). Almost 47% of respondents (n=253) observed a benefit to CMC due to COVID-19 related changes in healthcare delivery, including increased availability of virtual care and reduction in respiratory illness. Some (14.4%) reported that CMC were excluded from in-person learning when their peers without medical complexity were not.
Conclusion Canadian paediatricians reported that CMC experienced adverse health outcomes during the COVID-19 pandemic, including disruptions to family caregiving and community supports. These results highlight the need for healthcare, community and education policymakers to collaborate with families to optimize their health.
“What This Study Adds”
Children with medical complexity experienced adverse health outcomes related to the direct and indirect effects of the COVID-19 pandemic.
The COVID-19 pandemic has interrupted family caregiving, homecare support, access to education, and key supports for CMC and their families.
Canadian paediatricians observed benefits associated with structural changes relating to the COVID-19 pandemic, including the expansion of virtual care and the reduced incidence of respiratory illness
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project was supported by in-kind funding was provided through the Canadian Paediatric Surveillance Program, a joint program of the Canadian Paediatric Society and the Public Health Agency of Canada. No honorarium, or other form of payment was given to anyone to produce the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Canadian Paediatric Surveillance Program waived ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflict of Interest Disclosures: The authors have no conflicts of interest to disclose
Funding/Support. In-kind funding was provided through the Canadian Paediatric Surveillance Program, a joint program of the Canadian Paediatric Society and the Public Health Agency of Canada.
Ethics statement: Consent (from patients) is not required for public health surveillance purposes. We are able to collect the information without consent on behalf of PHAC under the Department of Health Act and the Public Health of Agency Act.
Consent statement: Physicians (paediatricians and paediatric subspecialists) provide their consent when participating in the Canadian Paediatric Surveillance Program.
Catherine Diskin and Peter Gill conceptualized and developed the study, convened the steering committee, carried out initial analyses, drafted and revised the initial manuscript. Dr. Peter Gill guided the study design.
All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Abbreviations
- AGMPs’
- aerosol generating medical procedures
- BC
- British Columbia
- COVID-19
- coronavirus-19
- CMC
- child with medical complexity
- CPSP
- Canadian Paediatric Surveillance Program
- IQR
- interquartile range
- LTC
- long-term care
- PPE
- personal protective equipment
- RSV
- respiratory syncytial virus
- SARS-CoV-2
- severe acute respiratory syndrome coronavirus
